West to build manufacturing facility in India
Will produce metal and elastomeric components for injectables
West Pharmaceutical Services has started the construction of a compression moulding facility in Sri City, India.
The plant will become part of West’s global supply chain for its pharmaceutical packaging components.
The 72,800m2 site in the Sri City Special Economic Zone (SEZ) will produce metal and elastomeric pharmaceutical components used in primary packaging of injectable medicines manufactured by West's pharmaceutical and biopharmaceutical customers in India and the wider Asia Pacific region.
Manufacture of elastomeric components is expected to begin in the first quarter of 2015, with sterilisation capacity available by 2016. The plan is to have 37,700m2 of manufacturing space by 2023.
‘This investment is important to our strategy of partnering with customers in India and the Asia Pacific region to help them provide medicines to patients more efficiently, reliably and safely,’ said Warwick Bedwell, president, Pharmaceutical Packaging Systems, Asia Pacific Region.
‘When the facility is completed, we anticipate a reduction in lead times for supply to our customers in India. By leveraging our global sourcing activities and process engineering expertise, we will be able to manage the overall costs of production.’
West plans to file Drug Master Files for the plant with the US FDA and Heath Canada's Bureau of Pharmaceutical Sciences.